Tucatinib is a inhibitor that helps treat breast cancer in HER2-positive patients with brain tumors. This medicine is made to stop the HER2 signals. The med comes in two forms—50 milligrams and 150 milligrams in these coated tablets.
Doctors usually suggest you take 300 mg a day, split between two doses with meals. Each bottle holds 60 tablets.
